Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|November 24, 1999
Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituentsS Bailey, B Bolognese, A Faller, et al.Circulatory Shock|August 1, 1992
Pentoxifylline treatment of sepsis in conscious Yucatan minipigsW R Law, V M Nadkarni, M A Fletcher, et al.Clinical Immunology and Immunopathology|July 1, 1989
Immunophenotyping in a multicenter study: the Transfusion Safety Study experienceM A Fletcher, S P Azen, B Adelsberg, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 24, 1997
HIV-1 infection in women is associated with severe nutritional deficienciesM K Baum, G Shor-Posner, G Zhang, et al.Psychosomatic Medicine|March 1, 1997
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane AndrewG Ironson, C Wynings, N Schneiderman, et al.Allergy|February 1, 1995
Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E statusM J Miguez-Burbano, G Shor-Posner, M A Fletcher, et al.Clinical Immunology and Immunopathology|May 1, 1990
Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the Transfusion Safety Study. The Transfusion Safety Study GroupJ W Parker, B Adelsberg, S P Azen, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.Pageof 15